MedPath

University of Alberta

University of Alberta logo
🇨🇦Canada
Ownership
Private
Established
1908-01-01
Employees
10K
Market Cap
-
Website
http://www.ualberta.ca

Rise Up After Breast Cancer

Not Applicable
Completed
Conditions
Body Image
Breast Cancer
Interventions
Behavioral: Exercise
Behavioral: Art Sculpting Class
First Posted Date
2019-09-13
Last Posted Date
2020-11-03
Lead Sponsor
University of Alberta
Target Recruit Count
12
Registration Number
NCT04088877
Locations
🇨🇦

University of Alberta, Edmonton, Alberta, Canada

Preoperative BNP: Epidemiological Patterns, Management Strategies and Cost Analysis of Care

Completed
Conditions
Myocardial Infarction Postoperative
Death, Cardiac
Myocardial Injury
Interventions
Other: Cardiac risk stratification using preoperative BNP measurement, followed by postoperative cardiac monitoring
Other: Use of traditional perioperative cardiac risk stratification only
First Posted Date
2019-09-04
Last Posted Date
2022-07-28
Lead Sponsor
University of Alberta
Target Recruit Count
333
Registration Number
NCT04077294
Locations
🇨🇦

University of Alberta Hospital Pre-Admission Clinic, Edmonton, Alberta, Canada

Physical Activity Promotion in Children and Adolescents With Single Ventricle Physiology (MedBike)

Not Applicable
Completed
Conditions
Hypoplastic Left Heart Syndrome
Physical Activity
Congenital Heart Defect
Interventions
Device: MedBIKE
First Posted Date
2019-08-14
Last Posted Date
2022-11-30
Lead Sponsor
University of Alberta
Target Recruit Count
4
Registration Number
NCT04056416
Locations
🇨🇦

University of Alberta, Edmonton, Alberta, Canada

BedMed-Frail: Does the Potential Benefit of Bedtime Antihypertensive Prescribing Extend to Frail Populations?

Not Applicable
Completed
Conditions
Hypertension
Dementia
Interventions
Other: Bedtime administration of the participant's pre-existing antihypertensive medications
First Posted Date
2019-08-13
Last Posted Date
2024-08-27
Lead Sponsor
University of Alberta
Target Recruit Count
776
Registration Number
NCT04054648
Locations
🇨🇦

Multiple Alberta Long Term Care Facilities, Edmonton, Alberta, Canada

A Pilot Randomized Controlled Trial of Intravenous N-acetyl Cysteine in STEMI

Phase 2
Completed
Conditions
STEMI
Interventions
First Posted Date
2019-07-17
Last Posted Date
2022-10-06
Lead Sponsor
University of Alberta
Target Recruit Count
44
Registration Number
NCT04023266
Locations
🇨🇦

University of Alberta Hospital, Edmonton, Alberta, Canada

The Impact of a Preoperative Nerve Block on the Consumption of Sevoflurane in Total Shoulder Arthroplasty

Phase 2
Terminated
Conditions
Rotator Cuff Injuries
Anesthesia; Functional
Interventions
First Posted Date
2019-07-16
Last Posted Date
2024-06-06
Lead Sponsor
University of Alberta
Target Recruit Count
17
Registration Number
NCT04020601
Locations
🇨🇦

University of Alberta Hospital, Edmonton, Alberta, Canada

The Impact of a Preoperative Nerve Block in Foot and Ankle Surgery on the Consumption of Sevoflurane

Phase 2
Withdrawn
Conditions
Anesthesia; Functional
Ankle Arthropathy
Ankle Arthritis
Interventions
First Posted Date
2019-07-16
Last Posted Date
2024-06-06
Lead Sponsor
University of Alberta
Registration Number
NCT04022057
Locations
🇨🇦

University of Alberta Hospital, Edmonton, Alberta, Canada

The Impact of an Epidural Anesthetic on the Consumption of Sevoflurane in Major Abdominal Surgery

Phase 2
Withdrawn
Conditions
Liver Diseases
Bowel Disease
Anesthesia; Functional
Pancreas Disease
Interventions
Drug: Ropivacaine-Sufentanil
Drug: Dextrose 5
First Posted Date
2019-07-16
Last Posted Date
2022-05-27
Lead Sponsor
University of Alberta
Registration Number
NCT04021264
Locations
🇨🇦

University of Alberta Hospital, Edmonton, Alberta, Canada

MRI Assessment of Pulmonary Edema in Acute Heart Failure

Recruiting
Conditions
Pulmonary Edema With Heart Failure
Acute Heart Failure
Interventions
Diagnostic Test: MRI
First Posted Date
2019-06-26
Last Posted Date
2024-07-03
Lead Sponsor
University of Alberta
Target Recruit Count
300
Registration Number
NCT03999138
Locations
🇨🇦

University of Alberta, Edmonton, Alberta, Canada

🇨🇦

University of Ottawa Heart Institute, Ottawa, Ontario, Canada

Target Controlled Infusion Using Propofol and Remifentanil for Moderate Sedation in Dentistry

Completed
Conditions
Sedative Adverse Reaction
Interventions
Combination Product: Propofol and Remifentanil administered by TCI pump
First Posted Date
2019-06-21
Last Posted Date
2020-01-23
Lead Sponsor
University of Alberta
Target Recruit Count
101
Registration Number
NCT03995134
Locations
🇨🇦

Dr. Douglas Lobb, Edmonton, Alberta, Canada

🇳🇿

Dr. Don Macalister, Auckland, New Zealand

© Copyright 2025. All Rights Reserved by MedPath